DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Online

The War in Ukraine and Good Clinical Practice

Complimentary for DIA members, this global webinar series shares the clinical trial challenges in Ukraine and the region. Join us to create strategies for the future.

Presenters

Sandor  Kerpel-Fronius, DrSc, MD

Sandor Kerpel-Fronius, DrSc, MD

Department of Pharmacology and Pharmacotherapy , Semmelweis University , Hungary

Dr. Kerpel-Fronius was born in Budapest, Hungary in 1940. He obtained medical diploma and board certificates in Clinical Laboratory Sciences and Clinical Pharmacology. He received PhD degree and DSc titles from the Hungarian Academy of Sciences. First, he worked in neurobiology at the Semmelweis University, later he led a clinical research group at the Hungarian National Institute of Oncology. Between 1989-2001 he worked in the international pharmaceutical industry. In 2001 he became Professor of Clinical Pharmacology at the Semmelweis University. In 2016 he was appointed Honorary Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He is member of the IFAPP Ethics Working Group.

Evgeny  Levenko, MD, PhD

Evgeny Levenko, MD, PhD

Country Manager, ARENSIA Exploratory Medicine GmbH, Germany

Sergii  Rasputniak

Sergii Rasputniak

Head, Laboratory & Clinical Practices Audit Department, The State Expert Center, Ministry of Health, Ukraine

Prior to joining SECMOH in 1999, he worked as an urologist. He is an author of more 70 articles on various topics related to clinical trials in Ukraine, including: inspection, expert evaluation of CT materials, ethical and regulatory issues. He was involved in the conduct of more than 500 inspections (clinical audits) of clinical trials in Ukraine (incl. those performed by inspectors from FDA, EMA and PMDA). In 2014-2016 he completed the Vilnius University Research Ethics Program and the Clarkson University Bioethics Program. In 2014, 2016, 2017, 2018 he participated in EU GCP Inspectors Working Group Workshops. In 2015 he completed “On-line EU GCP Inspectors Basic Training Course”.

Aneta  Sitarska-Haber, MD

Aneta Sitarska-Haber, MD

Associate Director, Regional Operational Delivery-Clinical Research Group, PPD, part of Thermo Fisher Scientific, Poland

Aneta Sitarska-Haber is associated with the clinical trials industry since 1998. She has medical background, graduated at the Medical University of Warsaw. Since 2005, she has been working at PPD Poland (part of Thermo Fisher Scientific), a global CRO company, currently as Associate Director of Clinical Research. She is responsible for supervising, coaching and training the clinical team (CRAs, remote monitors, CTC) developing the partnerships with site research networks and liaison with Patient Advocacy Groups by promoting patient centricity approach. She is a Vice-president of the GCPpl Association. She cooperates with the Medical Research Agency and is a member of the Polish Platform of EUPATI (European Patients' Academy).

Mark  Turner, MD, PhD, MRCP, FFPM

Mark Turner, MD, PhD, MRCP, FFPM

Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology, University of Liverpool, United Kingdom

Neonatologist with a special interest in early phase drug development and improving the availability of high quality medicines to children and babies. Has studied 20 medicines in neonates and pregnant women including antibiotics, excipients, treatments for in utero growth restriction, inotropes, postnatal steroids and surfactant. Current work is focused on developing research infrastructure for pediatric medicines research in Europe and beyond.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。